Related Experiment Video
Updated: May 27, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score
Germana Panattoni1, Pietro Desimone2, Federica Toto1
1Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy.
Insights
Cardiovascular disease (CVD) risk scores help identify high-risk patients for better prevention and management. This review guides selecting appropriate CVD risk scores for clinical practice.
Area of Science:
- Cardiology
- Preventive Medicine
- Health Risk Assessment
Background:
- Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality.
- European Society of Cardiology Guidelines advocate for risk prediction models in managing cardiovascular risk factors and promoting healthy behaviors.
- Risk models are crucial for identifying high-risk individuals in primary prevention to reduce adverse events and premature deaths.
Purpose of the Study:
- To review and guide the selection of appropriate cardiovascular disease (CVD) risk scores for diverse clinical practice settings.
- To highlight the importance of risk stratification in both primary and secondary CVD prevention.
- To emphasize the integration of conventional and emerging non-traditional markers in CVD risk assessment.
Main Methods:
- Literature review of current European Society of Cardiology guidelines and risk prediction models.
- Analysis of the role of CVD risk scores in primary and secondary prevention strategies.
- Discussion on the incorporation of conventional and non-traditional risk factors into risk stratification.
Main Results:
- Risk models integrate conventional factors to estimate 10-year CVD risk.
- Emerging non-traditional markers should be considered alongside conventional factors.
- Evaluating residual CVD risk is essential for optimal secondary prevention and identifying high-risk patients for intensive management.
Conclusions:
- Appropriate selection of CVD risk scores is vital for effective patient management and public health.
- Risk stratification aids in tailoring preventive strategies and intensive treatments for high-risk individuals.
- This review offers guidance on choosing the most suitable CVD risk score for different clinical scenarios.
Abstract:
Cardiovascular diseases (CVDs) remain a major cause of morbidity and mortality worldwide. The European Society of Cardiology Guidelines encourage the use of risk prediction models to enhance an adequate management of cardiovascular risk factors and the implementation of healthy behaviours. In primary prevention, estimating CVD risk is used to identify patients at high risk in order to enhance preventive strategies and decrease the incidence of unfavourable events and pre-mature cardiovascular deaths. Risk models integrate information on several conventional risk factors and estimate individual risk over a 10-year period. In addition to conventional risk factors, emerging non-traditional markers should be considered and mentioned in risk stratification. In secondary prevention, optimal management of patients include evaluation of residual CVD risk. The 10-year risk of recurrent events is not the same for all patients. The identification of high-risk patients is mandatory to prevent recurrent events and to allow to engage intensive treatments and follow-up strategies, representing an opportunity for major public health gain. This review provides a guide to evaluate which CVD risk score is appropriate for use in different settings in clinical practice.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pre-Procedural Guidelines for Assessing Blood Pressure
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

